	Cancer Nursing Interventions for Sexual Function and Satisfaction in Men with Prostate Cancer: A Systematic Review and Meta-analysis. Semin Oncol Nurs Birimo, Kerkez M, Bilgin A. PMID: 41763947 [PubMed - as supplied by publisher]
	A Long Noncoding RNA-based Classifier for Identifying More Aggressive Low-grade Ta Bladder Cancer with Elevated FGFR3 Activity. Eur Urol Oncol Thu Phung TA, Weng R, Black PC, Dyrskjøt L, de Jong JJ, Gibb EA. PMID: 41763905 [PubMed - as supplied by publisher]
	Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. Ann Oncol Gillessen S, Gallardo E, Choudhury A, Saad F, Soares A, Loriot Y, McDermott R, Rodriguez-Vida A, Isaacsson Velho P, Nolè F, Cruz F, Roumeguere T, Daugaard G, Yamamura R, Bompas E, Maroto P, Veiga FG, Skoneczna I, Martins da Trindade K, Mavignier Carcano F, Lecouvet F, Coens C, Poncet C, Fournier B, Tombal B. PMID: 41763609 [PubMed - as supplied by publisher]
	A2AR as a key target for immune microenvironment remodeling in prostate cancer. Transl Oncol Yan L, Yang Z, Zhao X, Chen Y, Wang Z. PMID: 41763068 [PubMed - as supplied by publisher]
	From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. Transl Oncol Hamed NW, Elbeljihy HS, Hussin SA, Fouda RM, Oy EK, W Magar R. PMID: 41762538 [PubMed - as supplied by publisher]
	Comparing the national cancer waiting times dataset with other linked electronic health records to measure treatment timeliness: A national cohort study of kidney cancer in England. Cancer Epidemiol Varma R, Mayne E, Parry MA, Nathan A, van der Meulen J, Bahl A, Stewart GD, Cowling TE. PMID: 41762537 [PubMed - as supplied by publisher]
	[(18)F]Fluciclovine PET/CT versus [(18)F]DCFPyL PET/CT in patients with biochemical recurrence of prostate cancer after robot-assisted radical prostatectomy: a prospective, single-center, single-arm, comparative imaging trial. Eur J Nucl Med Mol Imaging Luining WI, Vis AN, Donswijk ML, Koppes JCC, van Leeuwen PJ, Oudshoorn F, Cysouw MCF, Oprea-Lager DE. PMID: 41762267 [PubMed - as supplied by publisher]
	Toward Prostate Cancer Early Warning with a Self-Powered Wearable Biosensing Platform Integrated with Machine Learning. Adv Sci (Weinh) Xu J, Chen H, Yuan Q, Yin L, Tao Y, Wang H, Xue Y, Fu D, Pang H, Chong T, Xue L. PMID: 41761635 [PubMed - as supplied by publisher]
	A trial of risk-adapted prostate cancer screening in a federally supported health center network serving a high-risk population. Cancer Gann PH, Stackhouse N, Gastala N, Ma W, Wright ME, Watson K, Stepping C, King-Lee P, Xu Z, Patel T, Abern MR. PMID: 41761486 [PubMed - in process]
	Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. Cell Commun Signal Lee IT, Wang YL, Hong JH, Huang CY, Vo TTT, Lee WJ, Chiang CH. PMID: 41761243 [PubMed - as supplied by publisher]
	A multicenter study on preoperative WHO/ISUP grading of clear cell renal cell carcinoma using triphasic contrast-enhanced CT-based habitat imaging. BMC Med Imaging Zhang L, Shi N, Chen X, Shang S, Lu S, Li T, Liu Y, Han L, Ye J. PMID: 41761150 [PubMed - as supplied by publisher]
	Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial. Nat Med Mellema JJ, Stockem CF, Herberts C, Cheung SK, Vis DJ, van Rhijn BWG, Mertens LS, Boellaard TN, van Montfoort ML, Balduzzi S, de Feijter JM, van der Mijn JCK, Sharma S, El Naggar AC, Boormans JL, Franckena M, Meijer RP, Noteboom JL, Schaake EE, Robbrecht DGJ, Suelmann BBM, van der Heijden MS. PMID: 41760951 [PubMed - as supplied by publisher]
	Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. PMID: 41760529 [PubMed - as supplied by publisher]
	ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy. Eur Urol Focus Laccetti AL, Smith MR, Scher HI, Nowfar S, Einstein D, Martin B, Adorjan P, Dissanayake M, Verholen F, Gao X. PMID: 41760423 [PubMed - as supplied by publisher]
	Development and Validation of Radiomics and Clinical Models for Predicting Gleason Grades in Prostate Cancer Across Tumor Subregions and Clinical Factors: A Dual-Center Study. Acad Radiol Liu L, Yin P, Bao M, Wang J, Han B, He Y, Lu F, Yin L. PMID: 41760414 [PubMed - as supplied by publisher]
	Cost-Effectiveness of PSMA PET/CT as Single Procedure for Diagnosis and Staging High-Grade Prostate Cancer: A Single Center Experience. In Vivo Pepe P, Pepe L, Pepe G, Privitera R. PMID: 41760330 [PubMed - in process]
	The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab. In Vivo Fiala O, Tkadlecova M, Kopecky J, Hosek P, Studentova H, Vocka M, Mateju M, Lohynska R, Sikova D, Stransky P Jr, Kucera R, Zemankova A, Spisarova M, Priester P, Kouril J, Buchler T, Grmelova L, Melichar B, Poprach A. PMID: 41760301 [PubMed - in process]
	Urinary Amino Acid Profiling as a Non-invasive Diagnostic and Risk Stratification Tool in Prostate Cancer. In Vivo Zdobinska T, Luksanova H, Duskova K, Priman O, Slavenko M, Babjuk M, Vesely S. PMID: 41760295 [PubMed - in process]
	Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial. Cell Rep Med Ager CR, Obradovic A, McCann P, Chaimowitz M, Wang ALE, Shaikh N, Shah P, Pan SS, Laplaca CJ, Virk RK, Hill JC, Jugler C, DeFranco G, Bhattacharya N, Copple KR, Nguyen P, Scher HI, DeCastro GJ, Anderson CB, McKiernan JM, Spina CS, Stein MN, Runcie K, Drake CG, Califano A, Dallos MC. PMID: 41759531 [PubMed - as supplied by publisher]
	Unravelling Salvage Re-irradiation for Locally Recurrent Prostate Cancer: Challenges and Complexities. Clin Oncol (R Coll Radiol) Biolatti LV, Ismail N, Devi A, Zhong J, Bleaney CW, Choudhury A. PMID: 41759222 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176364

Page 1 of 8819



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy